Addition of atezolizumab to first-line chemotherapy is not cost effective in the US Clinical study 04 April 2020 Pages: 3 - 3
Bevacizumab plus paclitaxel not cost effective for HER2− MBC Clinical study 04 April 2020 Pages: 5 - 5
Botulinum toxin A cost effective for sialorrhoea in Australia Clinical study 04 April 2020 Pages: 6 - 6
Brexanolone may be cost effective for postpartum depression in USA Clinical study 04 April 2020 Pages: 7 - 7
Budget impact of introducing tildrakizumab for psoriasis treatment in US Clinical study 04 April 2020 Pages: 8 - 8
Burden of informal caregiving in Hungary, Poland and Slovenia Clinical study 04 April 2020 Pages: 9 - 9
Cardiac resynchronisation with defibrillator in HF: benefits at a cost Unknown 04 April 2020 Pages: 10 - 10
Changes in analgesic use after rescheduling of codeine in Australia Clinical study 04 April 2020 Pages: 11 - 11
COPD care bundles not cost effective in England and Wales Clinical study 04 April 2020 Pages: 12 - 12
Cost effective therapy for advanced RCC: avelumab or pembrolizumab? Clinical study 04 April 2020 Pages: 14 - 14
Cost effectiveness of colonoscopy for CRC screening depends on uptake Clinical study 04 April 2020 Pages: 15 - 15
Cost-effectiveness thresholds for Chagas vaccine during pregnancy in Mexico Clinical study 04 April 2020 Pages: 16 - 16
Durvalumab cost effective as consolidation treatment for NSCLC in Switzerland Clinical study 04 April 2020 Pages: 18 - 18
Impact of routine vaccination on obstetrics and gynaecology practices in the US Clinical study 04 April 2020 Pages: 23 - 23
Influenza vaccination cost effective in Mexican school children Clinical study 04 April 2020 Pages: 24 - 24
Liquid based cytology screening for cervical cancer cost effective in Germany Clinical study 04 April 2020 Pages: 25 - 25
Naloxone for opioid overdose in US: high cost, low dispensing rate Clinical study 04 April 2020 Pages: 27 - 27
Non-pharmacological treatment of cognitive impairment cost effective Unknown 04 April 2020 Pages: 28 - 28
Novel therapies for recurrent ovarian cancer: modest benefits at high cost Clinical study 04 April 2020 Pages: 29 - 29
Stopping follow-up for low-risk subsolid lung nodules cost-effective Clinical study 04 April 2020 Pages: 31 - 31
Substantial healthcare costs for people living with HIV in the US Clinical study 04 April 2020 Pages: 32 - 32
Urological complications after pelvic radiotherapy costly Clinical study 04 April 2020 Pages: 33 - 33
US breast cancer screening insurance costs in 40−49 age group Clinical study 04 April 2020 Pages: 34 - 34
Ustekinumab reduces costs and utilisation in US patients with Crohn's disease Clinical study 04 April 2020 Pages: 35 - 35